Givaudan stock: Bernstein keeps CHF 3,004 target for Givaudan stock

Published on 10/21/2026 at 16:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan schedules October 29, 2026 investor event. Givaudan stock costs EUR 4,255.50 on October 21, 2026, down 0.53 percent versus Tradegate.

Analyst target and reporting date

Bernstein retained an Underperform rating and a CHF 3,004 target on October 20, 2026.
Givaudan scheduled an investor presentation for October 29, 2026.
Givaudan stock costs EUR 4,255.50 at Lang & Schwarz on October 21, 2026 at 4:38 p.m. CEST, 0.53 percent below the Tradegate quote of October 20, 2026.

Givaudan CH0010645932 fotorealistisches Parfumeur-Atelier mit Reagenzgläsern, getrockneten Blüten und warmem goldenem Nachmittagslicht, Illustration mit AI erstellt.

Givaudan's latest analyst signal came from Bernstein Research on October 20, 2026: According to t-online, the firm retained an Underperform rating and a CHF 3,004 price target. At Lang & Schwarz, the stock was trading at EUR 4,255.50 on October 21, 2026 at 4:38 p.m. CEST, 0.53 percent below the Tradegate quote of EUR 4,278.00 dated October 20, 2026.

Investor event set for October 29

Givaudan has scheduled an investor presentation in Zurich for October 29, 2026, according to the company's investor page. The event gives investors a near-term date for management commentary after the company's nine-month sales update on October 13, 2026. The company lists fragrance, beauty, taste and wellbeing among its core markets.

Historical full-year figures provide the operating scale. In fiscal year 2025, Givaudan reported CHF 7,472 million in sales, up 5.1 percent on a like-for-like basis from fiscal year 2024, while EBITDA reached CHF 1,751 million and the EBITDA margin was 23.4 percent, according to Givaudan.

How far is the stock from its range?

On SIX, Givaudan last traded at CHF 3,941.00 on October 21, 2026 at 4:33 p.m. CEST. The same quote placed the 52-week range at CHF 2,566.00 to CHF 3,985.00, leaving the share 1.10 percent below its high. Its price-to-earnings ratio was 29.22 and its market capitalization was CHF 36.4 billion at that timestamp.

Valuation and next dates

The Bernstein target sits CHF 937.00 below the SIX price cited above, underscoring the gap between the current quotation and the latest negative analyst view. The company's investor calendar also lists a presentation in Paris on December 1, 2026. No earnings date is used here because the investor page does not identify a future results release as the next reporting event.

Comparison with peers

Givaudan: down 0.53 percent versus the Tradegate quote, price-to-earnings ratio 29.22, market capitalization CHF 36.4 billion.

Symrise (Xetra, EUR): up 0.40 percent on October 21, 2026, price-to-earnings ratio 37.91, market capitalization EUR 13.9 billion.

dsm-firmenich (Euronext Amsterdam, EUR): up 0.33 percent on October 21, 2026, price-to-earnings ratio minus 22.34, market capitalization EUR 26.4 billion.

The analyst target sets a lower bar

For investors, the key tension is the contrast between Givaudan's 2025 sales growth and Bernstein's cautious rating. The October 29 presentation is the next dated opportunity for management to address operating trends and the assumptions behind the analyst view.

Givaudan was trading at EUR 4,255.50 at Lang & Schwarz on October 21, 2026 at 4:38 p.m. CEST, 0.53 percent below the Tradegate quote of October 20, 2026 at EUR 4,278.00. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.